Correctable sources of disparities in cancer among minority elders

Medical Clinics of North America

Volumn 89, Issue 4, 2005, Pages 869-894

  Miles, Toni P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE DISTRIBUTION; CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL PRACTICE; DECISION MAKING; DIAGNOSTIC PROCEDURE; GERIATRICS; HEALTH CARE PERSONNEL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; UNITED STATES;

EID: 19944362557     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2005.03.002     Document Type: Review

References (74)

1. V.L. Shavers, and M.L. Brown Racial and ethnic disparities in the receipt of cancer treatment J Natl Cancer Inst 94 2002 334 357
2. National Cancer Institute. Cancer health disparities: fact sheet. Updated April 4, 2003. Available at: http://www.nci.nih.gov./cancertopics/factsheet/ cancerhealthdisparaties. Accessed October 13, 2004.
3. B.D. Smedly A.Y. Stith A.R. Nelson Unequal treatment: confronting racial and ethnic disparities in health care 2003 The National Academies Press Washington
4. K. Whitfield, and M. Hayward The landscape of health disparities among older adults Public Policy and Aging Report 13 2003 1 23
5. M. Aapro, M. Extermann, and L. Repetto Evaluation of the elderly with cancer Ann Oncol 11 2000 223 229
6. J. Rosenberg, and E. Small Prostate cancer update Curr Opin Clin Oncol 15 2003 217 221
7. K. Monson, D.A. Litvak, and R.J. Bold Surgery and the older patient: surgical oncology Arch Surg 138 2003 1061 1067
8. N.J. Nusbaum Rehabilitation and the older cancer patient Am J Med Sci 327 2004 86 90
9. M.D. Hayward, and M. Heron Racial inequality in active life expectancy among adult Americans Demography 36 1999 77 91
10. M.D. Hayward, E.M. Crimmins, and T.P. Miles The significance of socioeconomic status in explaining the gap in chronic health conditions Am Sociol Rev 65 2000 910 930
11. E.M. Crimmins, M. Johnston, and M.D. Hayward Age differences in allostatic load: an index of physiological dysregulation Exp Gerontol 38 2003 731 734
12. D.L. Blackwell, M.D. Hayward, and E.M. Crimmins Does childhood health affect chronic morbidity in later life? Soc Sci Med 52 2001 1269 1284
13. Recent trends in mortality for four major cancers by sex and race/ethnicity - US 1990-1998 MMWR Morb Mortal Wkly Rep 51 2002 49 53
14. Kim K. Improving the health of older Asian women. Presented at Improving the Health of Older Women of Color. Palo Alto, California, December 10-11, 2004.
15. Dr. Robert L. Hogue, 51, President-Elect Texas Academy of Family Physicians. NY Times, March 17, 2002.
16. P.B. Bach, H.H. Pham, and D. Schrag Primary care physicians who treat blacks and whites N Engl J Med 351 2004 575 584
17. J.G. Borer, J. Sherman, and M.C. Solomon Age and population specific PSA reference ranges J Urol 159 1998 444 448
18. American Cancer Society. ACS cancer detection guidelines, 1997. Available at: http://www.cancer.org/docroot/PED/content/ PED_2_3X_ACS_Cancer_Detection_Guidelines_36.asp?sitearea=PED. Accessed October 19, 2004.
19. American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology 2000;14:267. Available at: http://www.cancernetwork. com/journals/oncology/o0002e.htm#References. Accessed October 13, 2004.
20. American Academy of Family Physicians. Prostate cancer: what you need to know. Available at: http://familydoctor.org/361.xml. Accessed October 8, 2004.
21. American College of Physicians Screening for prostate cancer Ann Intern Med 126 1997 480 484
22. Crawford ED, Chia D, Andriole GL, et al. PSA testing interval reduction in screening intervals; data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) screening trial [abstract 4]. Presented at the Association of Clinical Oncology Annual Meeting. Orlando, Florida, May 18-21, 2002.
23. I.M. Thompson, D.K. Pauler, and P.J. Goodman Prevalence of prostate cancer among men with a prostate specific antigen level of less than 4.0 ng per milliliter N Engl J Med 350 2004 2239 2246
24. C. Marwick ACS sets blueprint for action against prostate cancer in African Americans. American Cancer Society JAMA 279 1998 418 419
25. A.P. Polednak Racial and ethnic differences in diseases 1989 Oxford University Press New York
26. R.J. Angel, and J.L. Angel Who will care for us? Aging and long-term care in multicultural America 1997 University Press New York
27. T. Rice, S. Stearns, and S. DesHarnais Do physicians cost shift? Health Aff (Millwood) 15 1996 215 225
28. Morey SS. AUA issues a policy report on PSA monitoring. Am Fam Physician. Available at: http://www.aafp.org/afp/20000815/practice.html.
29. J. Naitoh, R.L. Zeiner, and J.B. deKernion Diagnosis and treatment of prostate cancer Am Fam Physician 57 1998 1531 1539
30. E. Crimmins, M. Hayward, and Y. Saito Differentials in active life expectancy in the older population of the United States J Gerontol B Psychol Sci Soc Sci 51 1996 S111 S120
31. S. Katz, L. Branch, and M. Branson Active life expectancy N Engl J Med 309 1983 1218 1223
32. E. Crimmins, M. Hayward, and Y. Saito Changing mortality and morbidity rates and the health status and life expectancy of the older population Demography 31 1994 159 175
33. M.D. Hayward, S. Friedman, and H. Chen Career trajectories and older men's retirement J Gerontol B Psychol Sci Soc Sci 53 1998 S91 S103
34. A.M. Wolf, and D.M. Becker Cancer screening and informed patient discussions: truth and consequences Arch Intern Med 156 1996 1069 1072
35. A.S. Dunn, K.V. Shridharani, and W. Lou Physician-patient discussions of controversial cancer screening tests Am J Prev Med 20 2001 130 134
36. W.J. Catalona, D.S. Smith, and T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156 1161 [erratum appears in N Engl J Med 1991;325:1324]
37. W.J. Catalona, J.P. Richie, and F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men J Urol 151 1994 1283 1290
38. P. Vihko, M. Kontturi, and O. Lukkarinen Screening for carcinoma of the prostate: rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared Cancer 56 1985 173 177
39. S.A. Optenberg, and I.M. Thompson Economics of screening for carcinoma of the prostate Urol Clin North Am 17 1990 719 737
40. G.W. Chodak, P. Keller, and H.W. Schoenberg Assessment of screening for prostate cancer using the digital rectal examination J Urol 141 1989 1136 1138
41. W.J. Catalona, D.S. Smith, and T.L. Ratliff Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening JAMA 270 1993 948 954
42. W.H. Cooner, B.R. Mosley, and C.L. Rutherford Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen J Urol 143 1990 1146 1152 [discussion: 1152-4]
43. S.J. Jacobsen, E.J. Bergstralh, and H.A. Guess Predictive properties of serum prostate-specific antigen testing in a community setting Arch Intern Med 157 1997 1765 1766
44. K.C. Stange, S.J. Zyzanski, and T.F. Smith How valid are medical records and patient questionnaires for physician profiling and health services research? A comparison with direct observation of patient visits Med Care 36 1998 851 867
45. DOPC Writing Group Conducting the Direct Observation of Primary Care Study J Fam Pract 50 2001 345 352
46. K.C. Stange, S.J. Zyzanski, and C.R. Jaen Illuminating the 'black box': a description of 4454 patient visits to 138 family physicians J Fam Pract 46 1998 377 389
47. US Cancer Statistics Working Group. United States cancer statistics: 2001 incidence and mortality. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2004. Available at: http://www.cdc.gov/cancer/npcr/uscs/pdf/USCS.pdf.
48. Department of Health and Human Services. Centers for Disease Control and Prevention. Fact Sheet from the Division of Cancer Prevention and Control. Cancer registries: The Foundation for Cancer Prevention and Control, 2004. Available at: http://www.cdc.gov/cancer/npcr/npcrpdsf/NPCR-FS2003.pdf. Accessed October 13, 2004.
49. Anonymous From the Centers for Disease Control and Prevention: screening with prostate-specific antigen test - Texas 1997 MMWR Morb Mortal Wkly Rep 49 2000 818 820
50. R. Volk, and A.R. Cass The accuracy of primary care patients' self-reports of prostate-specific antigen testing Am J Prev Med 22 2002 56 58
51. C.G. Chute, L.A. Panser, and J.E. Oesterling The prevalence of prostatism: a population-based survey of urinary symptoms J Urol 150 1993 85 89
52. A. Micheli, E. Mugno, and V. Krogh EUROPREVAL Working Group: cancer prevalence in European registry areas Ann Oncol 13 2002 840 865
53. G. Giles How important are estimates of cancer prevalence? Ann Oncol 13 2002 815 816
54. Mariotto A, Gigli A, Capocaccia R, et al. Complete and limited duration cancer prevalence estimates. SEER Cancer Statistics Review, 1973-1999. Available at: http://seer.cancer.gov/csr/1973_1999/prevalence.pdf. Accessed October 18, 2004.
55. R.M. Merrill, R. Capocaccia, and E.J. Feuer Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program Int J Epidemiol 29 2000 197 207
56. M.H. Gail, L. Kessler, and D. Midthune Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality Biometrics 55 1999 1137 1144
57. R. Capocaccia, and R. De Angelis Estimating the completeness of prevalence based on cancer registry data Stat Med 16 1997 425 440
58. J. Byrne, L.G. Kessler, and S.S. Devesa The prevalence of cancer among adults in the United States: 1987 Cancer 69 1997 2154 2159
59. G. De Angelis, R. De Angelis, and L. Frova MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data Comput Methods Programs Biomed 44 1994 99 107
60. A.R. Feldman, L. Kessler, and M.H. Myers The prevalence of cancer: estimates based on the Connecticut Tumor Registry N Engl J Med 315 1986 1394 1397
61. A. Verdecchia, R. Capocaccia, and V. Egidi A method for the estimation of chronic disease morbidity and trends from mortality data Stat Med 8 1989 201 216
62. Miles TP, Bland J. Rates of multiple primary malignant neoplasms in older adults: SEER 1989-1999. Presented at the 7th International Society of Geriatric Oncology Cancer in the Elderly. Boston, Massachusetts, September 27-28, 2002.
63. S. Warren, and O. Gates Multiple primary malignant tumors: a survey of the literature and a statistical study Am J Cancer 16 1932 1358 1414
64. S.I. Hadju, and E.O. Hadju Multiple primary malignant tumors J Am Geriatr Soc 16 1968 16 26
65. T. Berge, L. Cederqvist, and J. Schoenebeck Multiple primary malignant tumours: an autopsy study of a circumscribed population Acta Pathol Microbiol Scand 76 1969 171 183
66. A.J. Haddow, J.F. Boyd, and A.C. Graham Multiple primary neoplasms in the Western Hospital Region, Scotland: a survey based on cancer registration data Scott Med J 17 1972 143 152
67. A. Aydinger, A. Karadeniz, and K. Uygun Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms Am J Clin Oncol 23 2000 364 370
68. S. Watanabe, T. Kodama, and Y. Shimosato Multiple primary cancers in 5,456 autopsy cases in the National Cancer Center of Japan J Natl Cancer Inst 72 1984 1021 1027
69. K. Engin Cancers in multiple primary sites Int Surg 79 1994 33 37
70. J.S. Spratt, and M.G. Hoag Incidence of multiple primary cancers per man-year of follow up: 20-year review from the Ellis Fischel State Cancer Hospital Ann Surg 164 1966 775 784
71. T.K. Lee, R.T. Myers, and M. Scharyj Multiple primary malignant tumors (MPMT): study of 68 autopsy cases (1963-1980) J Am Geriatr Soc 30 1982 744 753
72. O. Parkash Multiple primary malignancies: a statistical study based on autopsy data from 1943-1972 Virchows Arch A Pathol Anat Histol 375 1977 281 286
73. C. Demandante, D.A. Troyer, and T.P. Miles Multiple primary malignant neoplasms (MPMN): case report and a comprehensive review of the literature Am J Clin Oncol 26 2003 79 83
74. M.D. Hayward, T.P. Miles, F.P. Stafford for the Consortium of Social Science Associations Living longer, staying well: promoting good health for older Americans. Congressional briefing, April 27, 2001 2001 COSSA Washington DC